© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1
aDepartment of Preclinical and Clinical Pharmacology, University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy
bInstitute of Pharmacological Science, University of Siena, Siena, Italy
* Corresponding author. Tel.: +39-55-427-1288; fax: +39-55-427-1280 ledda{at}ds.unifi.it
Objective: The influence of hypoxia and endothelial loss on the responsiveness of vascular smooth muscle cells (VSMCs) to vascular endothelial growth factor (VEGF-A) was tested. Methods and results: Exposure to hypoxia induced a potentiation of cultured cell proliferation in response to either the agonist for the VEGF receptor 1 (flt-1) placental growth factor (PlGF-1) or to VEGF-A. This effect was mediated by the mitogen activated protein kinase (MAPK) cascade, since it was inhibited by the MAPK kinase inhibitor PD98059 and by the farnesyl transferase inhibitor II. Accordingly, PlGF-1 activated extracellular signal-regulated kinase1/2. In rat aortic rings deprived of endothelium and cultured in three-dimensional fibrin gels, an increased sprouting of tubular structures in response to VEGF-A was observed only under hypoxia. Studies on rat aorta preparations revealed an endothelium-dependent vasorelaxation in response to either VEGF-A or PlGF1, which was reversed to a contractile response in endothelium-deprived preparations exposed to hypoxia. Western blot and immunohistochemistry of endothelium-deprived preparations exposed to hypoxia showed flt-1 receptor expression in all medial cells. Conversely, flt-1 mRNA, of endothelium-deprived aortic preparations and of tubular structures, was unchanged by hypoxia. Conclusion: These findings demonstrate that experimental conditions mimicking pathological vascular injury can make VSMCs responsive to VEGF-A through the induction of functional flt-1 receptors.
KEYWORDS Endothelial factors, hypoxia/anoxia; Remodeling; Smooth muscle; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Orlandi, A. Ferlosio, G. Arcuri, M. G. Scioli, S. De Falco, and L. G. Spagnoli Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-{kappa}B/IAP-1 pathway Cardiovasc Res, September 16, 2009; (2009) cvp288v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Raisky, A. I. Nykanen, R. Krebs, M. Hollmen, M. A.I. Keranen, J. M. Tikkanen, R. Sihvola, L. Alhonen, P. Salven, Y. Wu, et al. VEGFR-1 and -2 Regulate Inflammation, Myocardial Angiogenesis, and Arteriosclerosis in Chronically Rejecting Cardiac Allografts Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 819 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakao, L. Taraseviciene-Stewart, K. Wood, C. D. Cool, and N. F. Voelkel Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L362 - L368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Khurana, L. Moons, S. Shafi, A. Luttun, D. Collen, J. F. Martin, P. Carmeliet, and I. C. Zachary Placental Growth Factor Promotes Atherosclerotic Intimal Thickening and Macrophage Accumulation Circulation, May 31, 2005; 111(21): 2828 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pfosser, M. Thalgott, K. Buttner, A. Brouet, O. Feron, P. Boekstegers, and C. Kupatt Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia Cardiovasc Res, February 15, 2005; 65(3): 728 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Parenti, L. Bellik, L. Brogelli, S. Filippi, and F. Ledda Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1978 - H1984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Torry, D. Mukherjea, J. Arroyo, and R. J. Torry Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation Reproductive Sciences, May 1, 2003; 10(4): 178 - 188. [Abstract] [PDF]
|
|